Cefalexin 250mg (and 500mg) - Wyniki wyszukiwania

Australia - angielski - Department of Health (Therapeutic Goods Administration)

cephalex cefalexin (as monohydrate) 500 mg capsules blister pack

pharmacor pty ltd - cefalexin monohydrate, quantity: 525.87 mg (equivalent: cefalexin, qty 500 mg) - capsule - excipient ingredients: lactose; magnesium stearate; colloidal anhydrous silica; titanium dioxide; brilliant blue fcf; quinoline yellow; purified water; gelatin; sodium lauryl sulfate - cephalexin is indicated in the treatment of the following infections when caused by susceptible strains of the designated microorganisms:,- respiratory tract infections caused by s. pneumoniae and group a beta-haemolytic streptococci (penicillin is the usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. cephalexin is generally effective in the eradication of streptococci from the nasopharynx; however, substantial data establishing the efficacy of cephalexin in the subsequent prevention of rheumatic fever are not available at present.),- bacterial sinusitis caused by streptococci, s. pneumoniae and s. aureus (methicillin-sensitive only),- otitis media due to s. pneumoniae, staphylococci,- skin and soft-tissue infections caused by staphylococci and/or streptococci,- genitourinary tract infections, including acute prostatitis caused by e. coli, p. mirabilis, and klebsiella sp.,the effectiveness of cephalexin in the treatment of bacterial infections of the brain and spinal column has not been established and cephalexin is not indicated in these conditions.,note: appropriate culture and susceptibility tests should be initiated prior to and during therapy to determine susceptibility of the causative organism to cephalexin. renal function studies should be performed when indicated.

Australia - angielski - Department of Health (Therapeutic Goods Administration)

cefalexin sandoz cefalexin monohydrate 250 mg capsules blister pack

sandoz pty ltd - cefalexin -

Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

cefalexin sandoz

sandoz new zealand limited - cefalexin monohydrate 525.8mg equivalent to cephalexin 500 mg; - capsule - 500 mg - active: cefalexin monohydrate 525.8mg equivalent to cephalexin 500 mg excipient: gelatin magnesium stearate microcrystalline cellulose titanium dioxide water